Exercise therapy for human immunodeficiency virus/AIDS patients: Guidelines for clinical exercise therapists

Jeanne Grace, Stuart SEMPLE, Susan Combrink

    Research output: Contribution to journalArticle

    14 Citations (Scopus)

    Abstract

    Human immunodeficiency virus (HIV) has infected > 60 million people since its discovery and 30 million people have died since the pandemic began. Antiretroviral therapy has transformed HIV infection from an acute to a chronic disease, increasing life expectancy but also adding to the potential side effects associated with drug therapy and the comorbidity accompanying longevity. Exercise can play a valuable role in the management of HIV/AIDS patients by addressing various symptoms and improving their quality of life, but the optimum mode, intensity, frequency, and duration of exercise that take the different clinical stages of the disease into consideration are inadequately known. Searches of Medline, Embase, Science Citation Index, CINAHL database, HealthSTAR, PsycINFO, Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database of Systematic Reviews, Physiotherapy Evidence Database (PEDro), and SPORTDiscus were conducted between 2000 and January 2014. Searches of published and unpublished abstracts were conducted, as well as a hand search of reference lists and tables of contents of relevant journals and books. Identified studies were reviewed for methodological quality. A total of 33 studies met the inclusion criteria. Most studies failed to indicate the optimum type (mode), intensity, frequency, and duration of aerobic and progressive resistive exercise prescribed to HIV-infected individuals in relation to the different clinical stages of the disease. The purpose of this review is to provide evidence-based recommendations after revision of exercise guidelines for HIV patients, by highlighting practical guidelines that clinical exercise therapists should consider when prescribing exercise for patients in different stages of the disease
    Original languageEnglish
    Pages (from-to)49-56
    Number of pages8
    JournalJournal of Exercise Science and Fitness
    Volume13
    Issue number1
    DOIs
    Publication statusPublished - 2015

    Fingerprint

    Exercise Therapy
    Acquired Immunodeficiency Syndrome
    HIV
    Guidelines
    Exercise
    Databases
    Pandemics
    Virus Diseases
    Life Expectancy
    Comorbidity
    Chronic Disease
    Quality of Life
    Drug Therapy

    Cite this

    @article{743c7a6d63374fd08ff1cf496a1da916,
    title = "Exercise therapy for human immunodeficiency virus/AIDS patients: Guidelines for clinical exercise therapists",
    abstract = "Human immunodeficiency virus (HIV) has infected > 60 million people since its discovery and 30 million people have died since the pandemic began. Antiretroviral therapy has transformed HIV infection from an acute to a chronic disease, increasing life expectancy but also adding to the potential side effects associated with drug therapy and the comorbidity accompanying longevity. Exercise can play a valuable role in the management of HIV/AIDS patients by addressing various symptoms and improving their quality of life, but the optimum mode, intensity, frequency, and duration of exercise that take the different clinical stages of the disease into consideration are inadequately known. Searches of Medline, Embase, Science Citation Index, CINAHL database, HealthSTAR, PsycINFO, Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database of Systematic Reviews, Physiotherapy Evidence Database (PEDro), and SPORTDiscus were conducted between 2000 and January 2014. Searches of published and unpublished abstracts were conducted, as well as a hand search of reference lists and tables of contents of relevant journals and books. Identified studies were reviewed for methodological quality. A total of 33 studies met the inclusion criteria. Most studies failed to indicate the optimum type (mode), intensity, frequency, and duration of aerobic and progressive resistive exercise prescribed to HIV-infected individuals in relation to the different clinical stages of the disease. The purpose of this review is to provide evidence-based recommendations after revision of exercise guidelines for HIV patients, by highlighting practical guidelines that clinical exercise therapists should consider when prescribing exercise for patients in different stages of the disease",
    keywords = "Aerobic exercise, CD4 count, Highly active antiretroviral therapy, Immunodeficiency progressive resistive exercise",
    author = "Jeanne Grace and Stuart SEMPLE and Susan Combrink",
    year = "2015",
    doi = "10.1016/j.jesf.2014.10.003",
    language = "English",
    volume = "13",
    pages = "49--56",
    journal = "Journal of Exercise Science and Fitness",
    issn = "1027-7323",
    publisher = "Elsevier",
    number = "1",

    }

    Exercise therapy for human immunodeficiency virus/AIDS patients: Guidelines for clinical exercise therapists. / Grace, Jeanne; SEMPLE, Stuart; Combrink, Susan.

    In: Journal of Exercise Science and Fitness, Vol. 13, No. 1, 2015, p. 49-56.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Exercise therapy for human immunodeficiency virus/AIDS patients: Guidelines for clinical exercise therapists

    AU - Grace, Jeanne

    AU - SEMPLE, Stuart

    AU - Combrink, Susan

    PY - 2015

    Y1 - 2015

    N2 - Human immunodeficiency virus (HIV) has infected > 60 million people since its discovery and 30 million people have died since the pandemic began. Antiretroviral therapy has transformed HIV infection from an acute to a chronic disease, increasing life expectancy but also adding to the potential side effects associated with drug therapy and the comorbidity accompanying longevity. Exercise can play a valuable role in the management of HIV/AIDS patients by addressing various symptoms and improving their quality of life, but the optimum mode, intensity, frequency, and duration of exercise that take the different clinical stages of the disease into consideration are inadequately known. Searches of Medline, Embase, Science Citation Index, CINAHL database, HealthSTAR, PsycINFO, Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database of Systematic Reviews, Physiotherapy Evidence Database (PEDro), and SPORTDiscus were conducted between 2000 and January 2014. Searches of published and unpublished abstracts were conducted, as well as a hand search of reference lists and tables of contents of relevant journals and books. Identified studies were reviewed for methodological quality. A total of 33 studies met the inclusion criteria. Most studies failed to indicate the optimum type (mode), intensity, frequency, and duration of aerobic and progressive resistive exercise prescribed to HIV-infected individuals in relation to the different clinical stages of the disease. The purpose of this review is to provide evidence-based recommendations after revision of exercise guidelines for HIV patients, by highlighting practical guidelines that clinical exercise therapists should consider when prescribing exercise for patients in different stages of the disease

    AB - Human immunodeficiency virus (HIV) has infected > 60 million people since its discovery and 30 million people have died since the pandemic began. Antiretroviral therapy has transformed HIV infection from an acute to a chronic disease, increasing life expectancy but also adding to the potential side effects associated with drug therapy and the comorbidity accompanying longevity. Exercise can play a valuable role in the management of HIV/AIDS patients by addressing various symptoms and improving their quality of life, but the optimum mode, intensity, frequency, and duration of exercise that take the different clinical stages of the disease into consideration are inadequately known. Searches of Medline, Embase, Science Citation Index, CINAHL database, HealthSTAR, PsycINFO, Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database of Systematic Reviews, Physiotherapy Evidence Database (PEDro), and SPORTDiscus were conducted between 2000 and January 2014. Searches of published and unpublished abstracts were conducted, as well as a hand search of reference lists and tables of contents of relevant journals and books. Identified studies were reviewed for methodological quality. A total of 33 studies met the inclusion criteria. Most studies failed to indicate the optimum type (mode), intensity, frequency, and duration of aerobic and progressive resistive exercise prescribed to HIV-infected individuals in relation to the different clinical stages of the disease. The purpose of this review is to provide evidence-based recommendations after revision of exercise guidelines for HIV patients, by highlighting practical guidelines that clinical exercise therapists should consider when prescribing exercise for patients in different stages of the disease

    KW - Aerobic exercise

    KW - CD4 count

    KW - Highly active antiretroviral therapy

    KW - Immunodeficiency progressive resistive exercise

    UR - http://www.scopus.com/inward/record.url?scp=84929271387&partnerID=8YFLogxK

    UR - http://www.mendeley.com/research/exercise-therapy-human-immunodeficiency-virusaids-patients-guidelines-clinical-exercise-therapists

    U2 - 10.1016/j.jesf.2014.10.003

    DO - 10.1016/j.jesf.2014.10.003

    M3 - Article

    VL - 13

    SP - 49

    EP - 56

    JO - Journal of Exercise Science and Fitness

    JF - Journal of Exercise Science and Fitness

    SN - 1027-7323

    IS - 1

    ER -